LPCN
Lipocine·NASDAQ
--
--(--)
--
--(--)
LPCN fundamentals
Lipocine (LPCN) released its earnings on Aug 5, 2025: revenue was 622.85K (YoY +595.42%), beat estimates; EPS was -0.41 (YoY +26.79%), missed estimates.
Revenue / YoY
622.85K
+595.42%
EPS / YoY
-0.41
+26.79%
Report date
Aug 5, 2025
Earnings Call
6:00 AM on Aug 5, 2025
Meeting link.Earnings
EPS
Revenue
Revenue & Expenses
LPCN has released its 2025 Q4 earnings report, with revenue of 1.15M, reflecting a YoY change of -67.19%, and net profit of -2.37M, showing a YoY change of -232.99%. The Sankey diagram below clearly presents LPCN's revenue sources and cost distribution.
Key Indicators
Lipocine (LPCN) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
Lipocine (LPCN)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
Lipocine (LPCN)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
Lipocine (LPCN)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does Lipocine (LPCN) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track Lipocine (LPCN) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from Lipocine’s earnings call?Did Lipocine beat or miss consensus estimates last quarter?What is Lipocine's latest dividend and current dividend yield?What is the market's earnings forecast for Lipocine next quarter?What does Lipocine do and what are its main business segments?What is Lipocine's gross profit margin?What factors drove the changes in Lipocine's revenue and profit?What were the key takeaways from Lipocine's earnings call?
